|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
WILLIAM LEE | Jin-Long Lin | Alex Huang | (02)25710269 | 5F-6,No.23 Sec.1.Chang-An E. Rd .,Taipei 104, Taiwan , R.O.C. | 2002/03/04 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | As a life commitment to human being, BIOTEQUE CORPORATION provides Bloodline Set, A.V. Fistula Needle and IV Bags to Hemodialysis patients and other H.D. medical accessories such as Drainage Bag, IV Infusion Set, Burette, Surgical Tube. BIOTEQUE also produces high tech. TPU (Thermo Poly Urethane) implanted catheters such as Pigtail Drainage Catheter and Double J Catheter. All products are distributed in global marketing with success . |
Market Information ( 2024/03/28 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
169.791 | 126.00 | 124.00 | 126.00 | 1.50 | 207 | .00 | 787 | 0 | |||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/03/28) |
TPEx measures adopted (2024/03/28) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | Y | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |